HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
2022 Rome Action Plan on Paediatric HIV & TB
4M Network of Mentor Mothers living with HIV (UK)
The 4M Network of Mentor Mothers living with HIV (UK), alongside other Community Based Organisations commits to:
​
72. Supporting the design, implementation and messaging of research conducted according to Call to Action principles. More specifically, to ensure representation of women living with HIV and, as such, to:
-
Engage as partners in each stage of the HIV treatment and prevention research and surveillance process, including identification of research questions, protocol development, study implementation & results interpretation and dissemination.
-
Take the lead in building community research literacy, peer education and advocacy on the inclusion of pregnant women in clinical trials & active surveillance programmes for HIV agents.
-
Partner with researchers to develop tools to aid in communication about the need for clinical trials & surveillance in pregnancy, the interpretation & application of their findings, when they are available.
-
​
All partners commit to:
​
163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment.
​
164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care.
​
165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.
​
166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil
society to monitor progress regarding uptake and implementation of essential diagnostic tools.
​
-